HD-OPM Archive
Topics › Risk assessment & lab tests

CHIP (clonal hematopoiesis): a little-known risk factor for heart disease and stroke

Gokhan Can · Apr 08, 2024 · ♥ 5 reactions · 3 comments · original Facebook post
Risk assessment & lab testsHeart attack, stroke & proceduresCancer
AI summary & key facts

Explains clonal hematopoiesis of indeterminate potential: blood cells carrying acquired mutations that raise the risk of blood cancers, coronary disease and stroke. It becomes more common with age, can be detected with a next-generation sequencing panel, and has no specific treatment yet. The post notes testosterone therapy and anything strongly stimulating bone marrow may help CHIP expand.

CHIP

CHIP is a relatively unknown major risk factor for heart disease, stroke and deaths.

What is CHIP?

CHIP prevelance by age?

Effect of hormone replacement therapy (testosterone in particular) on CHIP?

Can you get tested for CHIP?

Is there a treatment for CHIP?

What are the effects of having a CHIP?

  1. Blood cancers: CHIP mutations are associated with a higher likelihood of developing blood cancers -- around 0.5-1% per year.
  2. Cardiovascular disease: Individuals with CHIP have over two-fold higher risk of coronary heart disease compared to those without the mutation.
  3. Stroke: CHIP may contribute to the development of stroke by promoting inflammation and the formation of blood clots.
  4. Increased mortality: Individuals with CHIP have a higher overall mortality rate compared to those without the mutation.
  5. Inflammatory conditions: CHIP has been linked to an increased risk of developing inflammatory diseases such as rheumatoid arthritis and other autoimmune disorders.

Can you pass CHIP to your children?

#chip#stroke#heartdisease#cancer#riskfactors#hormones#testosterone#mortality
← newer: Comment on CVD death peaks lining up with COVID wavesolder: Comment: drugs that don't work get pulled, unlike approved c →